James A. Geraghty, Director at JUNIPER PHARMACEUTICALS INC (JNP), bought 12,000 shares at $10.46 ($126K) on 2015-08-06, disclosed to the SEC on 2015-08-10.
Open-market purchase of $126k JNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| VYGR | BUY | 2018-08-21 | $110K | — | Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |